Pepto Bismol 32-Count Tablets Recalled for Insanitary Distribution Conditions
Gold Star Distribution Inc. is recalling all lots of Pepto Bismol 32-count tablets distributed nationwide due to Current Good Manufacturing Practice deviations—insanitary conditions and rodent activity identified at their distribution center.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II precautionary recall based on identified insanitary conditions and rodent activity at the distribution facility. No actual product contamination, illness, or injury has been reported. The recall is classified as a voluntary precautionary action in response to Current Good Manufacturing Practice deviations.
Plain-English summary
Pepto Bismol 32-count tablets distributed by Gold Star Distribution Inc. are being recalled due to Current Good Manufacturing Practice (CGMP) deviations at the firm's distribution center. The FDA identified insanitary conditions, including rodent exposure and activity, at the facility where these products were handled and distributed.
All lots of Pepto Bismol 32-count tablets that were within expiration dates and distributed by Gold Star Distribution Inc. are affected. The recall covers products distributed throughout the United States.
Consumers who have purchased affected products should not use them. If you have this product, dispose of it safely or return it to your place of purchase. Contact Gold Star Distribution Inc. with questions about the recall.
The recalled product
- Product
- PEPTO BISMOL 32CT
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Category
- Drug — Antacid
- Hazard
- insanitary-conditions
- rodent-exposure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27